[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Quest Diagnostics Inc (DGX)

Quest Diagnostics Inc (DGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Market News and Commentary

Is Quest Diagnostics Stock Underperforming the S&P 500?

With a market cap of $21.9 billion, Quest Diagnostics Incorporated (DGX) is a leading provider of diagnostic testing services in the United States and internationally. The company operates through two primary business groups - Diagnostic Information Services and Diagnostic Solutions, serving a wide range of clients including physicians, hospitals, insurers, and government agencies. 

Companies valued at $10 billion or more are generally classified as “large-cap” stocks, and Quest Diagnostics fits this criterion perfectly, exceeding the mark. Quest focuses on accelerating growth through strategic partnerships and innovation, while driving operational excellence across its customer value chain and IT infrastructure.

Fundamentals

See More
  • Market Capitalization, $K 21,585,718
  • Shares Outstanding, K 110,696
  • Annual Sales, $ 11,035 M
  • Annual Income, $ 992,000 K
  • EBIT $ 1,761 M
  • EBITDA $ 2,331 M
  • 60-Month Beta 0.59
  • Price/Sales 1.98
  • Price/Cash Flow 13.03
  • Price/Book 2.86

Options Overview Details

View History
  • Implied Volatility 23.24% (-0.54%)
  • Historical Volatility 20.08%
  • IV Percentile 50%
  • IV Rank 43.24%
  • IV High 31.28% on 04/20/26
  • IV Low 17.11% on 08/15/25
  • Expected Move (DTE 28) 6.80 (3.49%)
  • Put/Call Vol Ratio 21.62
  • Today's Volume 1,380
  • Volume Avg (30-Day) 553
  • Put/Call OI Ratio 0.73
  • Today's Open Interest 10,320
  • Open Int (30-Day) 9,075
  • Expected Range 188.20 to 201.80

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 18 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $2.81
  • Number of Estimates 9
  • High Estimate $2.89
  • Low Estimate $2.75
  • Prior Year $2.62
  • Growth Rate Est. (year over year) +7.25%

Price Performance

See More
Period Period Low Period High Performance
1-Month
187.06 +4.24%
on 05/19/26
207.50 -6.02%
on 06/11/26
+5.16 (+2.72%)
since 05/18/26
3-Month
186.23 +4.71%
on 05/08/26
209.79 -7.05%
on 04/21/26
-0.23 (-0.12%)
since 03/18/26
52-Week
164.65 +18.43%
on 07/15/25
213.50 -8.67%
on 02/27/26
+15.22 (+8.47%)
since 06/18/25

Most Recent Stories

More News
Is Quest Diagnostics Stock Underperforming the S&P 500?

While Quest Diagnostics has lagged behind the S&P 500 Index over the past year, analysts are moderately optimistic about the stock’s prospects.

DGX : 195.00 (-1.40%)
$SPX : 7,500.58 (unch)
TMO : 464.61 (+0.63%)
Is Labcorp Holdings Stock Underperforming the Nasdaq?

Labcorp Holdings has underperformed the Nasdaq over the past year, but analysts are highly optimistic about the stock’s prospects.

$NASX : 26,517.93 (unch)
DGX : 195.00 (-1.40%)
LH : 255.82 (-1.44%)
UTI-causing Bacteria Resistant to Current Drugs, Finds National Study by Hackensack Meridian CDI and Quest Diagnostics

Published in Nature Communications , the new study finds that nearly 70% of a common bacterial strain that causes urinary tract infections, pneumonia and wound infections was non-susceptible to...

DGX : 195.00 (-1.40%)
Quest Diagnostics to Release Second Quarter Financial Results on July 23, 2026

SECAUCUS, N.J. , June 17, 2026 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, announced today that it will report its second quarter 2026...

DGX : 195.00 (-1.40%)
Quest Diagnostics Unveils Achievements in Healthcare Access, Employee Engagement and Environmental Sustainability in 2025 Corporate Responsibility Report

SECAUCUS, N.J. , June 16, 2026 /PRNewswire/ -- Quest Diagnostics  (NYSE: DGX), a leader in diagnostic information services, today unveiled its 2025 Corporate Responsibility Report .

DGX : 195.00 (-1.40%)
Digi Power X Secures NVIDIA Vera Rubin Systems, Advancing its AI Infrastructure and Strengthening the NeoCloudz Platform

MIAMI, FL / ACCESS Newswire / June 3, 2026 / Digi Power X Inc. (Nasdaq:DGXX)(Cboe Canada:DGX) (the "Company" and "Digi Power X"), an AI data center infrastructure operator, today announced a $35 million...

DGX : 195.00 (-1.40%)
DGX.NE : 9.2600 (-2.11%)
DGX.VN : 3.790 (+5.28%)
DGXX : 6.75 (+0.90%)
3 Reasons to Sell DGX and 1 Stock to Buy Instead

3 Reasons to Sell DGX and 1 Stock to Buy Instead

DGX : 195.00 (-1.40%)
Quest Diagnostics Stock: Analyst Estimates & Ratings

Quest Diagnostics is keeping analysts reasonably upbeat as steady execution and momentum continue supporting Wall Street confidence.

XLV : 149.40 (-0.87%)
DGX : 195.00 (-1.40%)
$SPX : 7,500.58 (unch)
1 Profitable Stock to Own for Decades and 2 We Avoid

1 Profitable Stock to Own for Decades and 2 We Avoid

ROKU : 138.07 (+0.57%)
DGX : 195.00 (-1.40%)
NVR : 6,490.93 (+3.43%)
Quest Diagnostics Declares Quarterly Cash Dividend

SECAUCUS, N.J. , May 19, 2026 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, today announced that its Board of Directors declared a quarterly cash...

DGX : 195.00 (-1.40%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Weakest short term outlook on maintaining the current direction.

Relative Strength just crossed below 50%. The market is indicating support for a bearish trend.

See More Share

Business Summary

Quest Diagnostics, Inc. is the provider of commercial laboratory services. Quest provides lab testing services to physicians, hospitals, managed care organizations, employers, government institutions and other clinical laboratories. The company consists of 2 business groups - Diagnostic Information Services...

See More

Key Turning Points

3rd Resistance Point 201.95
2nd Resistance Point 199.69
1st Resistance Point 197.35
Last Price 195.00
1st Support Level 192.74
2nd Support Level 190.48
3rd Support Level 188.14

See More

52-Week High 213.50
Last Price 195.00
Fibonacci 61.8% 194.84
Fibonacci 50% 189.07
Fibonacci 38.2% 183.31
52-Week Low 164.65

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.